NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

CKD Specific Telemonitoring Platform to Minimize Adverse Outcomes in High Risk CKD Patients

RecruitingNA

Sponsor: University of Manitoba

Conditions: Chronic Kidney Disease Stage 5, End Stage Renal Disease

Interventions: VIEWER virtual care platform

Countries: Canada

The main purpose of this trial is to determine whether the addition of the VIEWER virtual care platform to usual care will lead to a reduction in composite emergency department (ED) visits and/or hospitalizations/or increase the perceived safety of virtual care among patients and providers.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* \>18 years of age
* Patient or primary caregiver can read and speak English
* Patient or patients substitute decision maker is able to provide informed consent
* Patient or primary care giver cognitively and physically capable and willing to use the VIEWER mobile application and perform self-measurements (i.e. weight, BP, etc.)
* Have stage 5 CKD (2 measurements of eGFR \<15ml/min/1.73m2); eGFR will be calculated with the CKD-EPI equation, or have \>40% chance of beginning dialysis in the next 2 years based on the Kidney Failure Risk Equation
* Followed in a multidisciplinary CKD clinic

Exclusion Criteria:

* Inability of self or caregiver assisted self-monitoring using VIEWER

Locations (5)

Winnipeg, Manitoba, Canada
Winnipeg, Manitoba, Canada
Winnipeg, Manitoba, Canada
London, Ontario, Canada
Scarborough Village, Ontario, Canada